Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dengue Vaccine Efficacy: Not a Zero Sum Game.

Literature DB >> 27694632

Dengue Vaccine Efficacy: Not a Zero Sum Game.

Scott B Halstead¹.
1. Rockville, Maryland, USA.

Abstract

Mesh：

Substances：
Dengue Vaccines

Year: 2016 PMID： 27694632 DOI： 10.1093/infdis/jiw458

Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

Review 1. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner.

Authors: Scott B Halstead
Journal: Cold Spring Harb Perspect Biol Date: 2018-06-01 Impact factor: 10.005

Review 2. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination.

Authors: Stephen S Whitehead; Kanta Subbarao
Journal: Cold Spring Harb Perspect Biol Date: 2018-06-01 Impact factor: 10.005

Review 3. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.

Authors: Esteban Ortiz-Prado; Katherine Simbaña-Rivera; Lenin Gómez-Barreno; Mario Rubio-Neira; Linda P Guaman; Nikolaos C Kyriakidis; Claire Muslin; Ana María Gómez Jaramillo; Carlos Barba-Ostria; Doménica Cevallos-Robalino; Hugo Sanches-SanMiguel; Luis Unigarro; Rasa Zalakeviciute; Naomi Gadian; Andrés López-Cortés
Journal: Diagn Microbiol Infect Dis Date: 2020-05-30 Impact factor: 2.803

Dengue Vaccine Efficacy: Not a Zero Sum Game.

Review 1. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner.

Review 2. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination.

Review 3. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.

4. Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study.

5. Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection.

6. Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine.